Dr. Benjamin Kelmendi and a team of researchers at Yale University in New Haven, Connecticut, are studying the effects of MDMA on prefrontal and amygdala activation in individuals with posttraumatic stress disorder (PTSD), by fMRI. This study is an investigator-initiated trial and is currently recruiting and expected to start in November of 2021. To learn more, visit the official study page on clinicaltrials.gov.
